会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Hemostatic patch
    • 止血补片
    • US5643596A
    • 1997-07-01
    • US474127
    • 1995-06-07
    • Thaddeus P. PrussJames A. Will
    • Thaddeus P. PrussJames A. Will
    • A61F13/00A61F13/02A61L15/44A61L15/58A61L15/64A61L24/00A61L26/00A61K9/70
    • A61L26/009A61F13/0203A61L15/44A61L15/64A61L24/0015A61L24/0042A61F2013/00221A61F2013/00472A61L2300/418A61L2300/434A61L2400/04
    • A fibrogen-free substrate having as a hemostatic agent on a surface thereof a mixture of a clot-promoting amount of thrombin and an amount of epsilon aminocaproic acid (EACA) effective to accelerate the rate of blood clotting induced by the thrombin is useful as a hemostatic patch which is safe, inexpensive and which rapidly controls bleeding from a wound. A patch which rapidly stanches the flow of blood from a lesion on a parenchymal organ by pressing it against the surface of the organ for 3-5 minutes, is produced by applying thrombin, EACA and CaCl.sub.2 to a rigid sheet of biodegradable foam, such as an absorbable gelatin sponge, and compressing the dry sheet to produce a flexible sheet which conforms to the contour of the organ without the necessity of pre-moistening. The problem associated with thrombin-fibrinogen glues of adhesion of the wounded surface of the organ to adjacent tissue is avoided by applying the hemostatic agent to only the wound-contacting face of the sheet.
    • 在其表面具有止血剂作为止血剂的无纤维素底物可有效促进由凝血酶引起的血液凝固速度的促凝血量的凝血酶与ε氨基己酸(EACA)的量的混合物,作为 止血补片是安全,便宜,并快速控制伤口出血。 通过将凝血酶,EACA和CaCl 2施用于可生物降解的泡沫塑料的刚性片材,例如 可吸收的明胶海绵,并压缩干燥片材以产生符合器官轮廓的柔性片材,而不需要预润湿。 通过将止血剂仅施加到片材的伤口接触面上来避免与器官的受伤表面对相邻组织的粘附的凝血酶 - 纤维蛋白原胶粘剂相关的问题。